USPTO serial 79252478
NIKON
Reviewed by CopyMark Law Group
Reg. 5958271Status 709
- Filing date
- Status date
- Registration date
- Jan 14, 2020
- Examiner
- CROWLEY, SEAN MICHAEL
- Law office
- TMO LAW OFFICE 116
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NIKON?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Charles T. J. Weigell
Charles T. J. Weigell Fross Zelnick Lehrman & Zissu, P.C.151 West 42nd Street, 17th FloorNew York, NY 10036UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Industrial chemicals; chemicals for use in industry and science; lithography chemicals; photographic chemicals; chemicals for use in semiconductor manufacturing; industrial chemicals for research or scientific purposes; chemicals for use in biotechnological manufacturing processes and biotechnological product development; chemical reagents for non-medical purposes; chemical reagents for research or scientific purposes; chemical agents being industrial chemicals for research or scientific purposes; chemical agents for use in cell and tissue growth applications, for research and scientific purposes; bacterial preparations, other than for medical and veterinary use; cell growth media for growing biological cells; cell growth media for growing biological cells for research or scientific purposes; cell growth media for growing cells for use in scientific research; cells for research or scientific purposes; assays for research purposes | SECTION 71 - CANCELLED | — |
| 005 | Protein arrays for medical diagnostic use; proteins in the nature of enzymes for medical use; cells for medical use; microorganisms and cultures for medical use; cultures of microorganisms for medical use; culture media for use in cultivating human, animal, and plant cells; pharmaceutical preparations; pharmaceutical preparations for medical purposes used in chemotherapy, immunotherapy, and gene therapy; pharmaceutical preparations for regenerative medical purposes; pharmaceutical preparations for gene therapy purposes; pharmaceutical preparations for chemotherapy, immunotherapy and gene therapy research and scientific purposes; semen for artificial insemination; cell culture reagents for medical or clinical medical use; sera and reagents for biological and pharmaceutical research and for the manufacture of pharmaceutical products, for oncological; medical diagnostic reagents and assays for testing of body fluids; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; chemicals for medical purposes; chemicals for regenerative medical purposes; chemicals for gene therapy purposes; chemical reagents for medical purposes; chemical reagents for regenerative medical purposes; chemical reagents for gene therapy purposes; chemical agents for medical purposes; chemical agents for regenerative medical purposes; chemical agents for gene therapy purposes; cell growth media for growing biological cells for medical purposes; cell growth media for growing biological cells for regenerative medical purposes; cell growth media for growing biological cells for gene therapy purposes | SECTION 71 - CANCELLED | — |
| 010 | Medical surgical apparatus and surgical instruments and replacement parts and replacement fittings therefor; medical imaging apparatus; medical apparatus and instruments for diagnostic radiopharmaceutical use; medical apparatus and instruments for regenerative medical gene therapy purposes; medical apparatus and instruments for stem cell regenerative medical purposes; medical apparatus and instruments for gene therapy purposes; medical apparatus and instruments used for cell culture and replacement parts and replacement fitting therefor; medical apparatus and instruments used for cell culture and parts and fitting therefor, namely, bioreactors; cell culture apparatus for medical use, namely, cell culture chambers; cell culture apparatus for regenerative medical purposes being cell culture chambers; cell culture apparatus for regenerative medical purposes, namely, tissue engineering chambers and bioreactors; cell culture apparatus for gene therapy purposes | SECTION 71 - CANCELLED | — |
| 035 | Retail store services featuring cells for research or scientific use; online, telephone and facsimile retail ordering services and mail order or electronic retail catalog services featuring cells for research or scientific use; retail store services featuring cells for medical use; online, telephone and facsimile retail ordering services and mail order or electronic retail catalog services featuring cells for medical use; business consultancy services relating to manufacturing | SECTION 71 - CANCELLED | — |
| 039 | Storage of cells; storage of cells for medical purposes; storage of cells for regenerative medical purposes; storage of cells for gene therapy purposes; storage of cells for research or scientific purposes; storage of goods; warehousing services; temporary safekeeping of personal belongings; cryogenic storage being biomedical services, namely, the storage of human cells for medical use | SECTION 71 - CANCELLED | — |
| 040 | Custom production and processing of proteins and chemicals for others; custom manufacture of cells for others; custom manufacture of cells for medical purposes for others; custom manufacture of cells for regenerative medical purposes for others; custom manufacture of cells for gene therapy purposes for others; custom manufacture of cells for research or scientific purposes for others; custom manufacture of cell tissues for others; custom processing of cells for others; custom processing of cells for medical purposes for others; custom processing of cells for regenerative medical purposes for others; custom processing of cells for gene therapy purposes for others; custom processing of cells for research or scientific purposes for others; providing information and advices about manufacturing cells; providing information and advices about manufacturing cells for medical purposes; providing information and advices about manufacturing cells for regenerative medical purposes; providing information and advices about manufacturing cells for gene therapy purposes; providing information and advices about manufacturing cells for research or scientific purposes; custom manufacture and processing of chemicals, chemical products and pharmaceuticals for others; custom manufacture and processing of cells for research or scientific use for others; processing of artificial limbs or artificial teeth, including processing of medical materials; production being manufacturing and processing of chemicals, ingredients for pharmaceuticals, and cells for research and scientific purposes; manufacture of bacteriological cultures, buffer solution, and reagents for others; cryogenic preservation | SECTION 71 - CANCELLED | — |
| 042 | Custom research and development for medical purposes for others; custom research and development of cell and gene therapy products; custom research and development for medical purposes for others; custom research and development for regenerative medical purposes for others; custom research and development for gene therapy purposes for others; custom research and development for research or scientific purposes for others; custom cultivation of cells and tissues for others in the nature of new product development; custom cultivation of cells and tissues for the development of new cell and gene therapy products of others; custom cultivation of cells and tissues for medical purposes for others in the nature of new product development; custom cultivation of cells and tissues for medical purposes in the nature of the development of new cell and gene therapy products of others; custom cultivation of cells and tissues for regenerative medical purposes for others in the nature of new product development; custom cultivation of cells and tissues for regenerative medical purposes in the nature of the development of new cell and gene therapy products of others; custom cultivation of cells and tissues for gene therapy purposes for others in the nature of new product development; custom cultivation of cells and tissues in the nature of the development of new cell and gene therapy products of others; custom cultivation of cells and tissues for research or scientific purposes for others in the nature of new product development; custom cultivation of cells and tissues in the nature of bioengineering for research or scientific purposes for others; testing, inspection or research of cells and providing information and consultancy therefor; testing, inspection or research of cells for medical purposes and providing information and consultancy therefor; testing, inspection or research of cells for regenerative medical purposes and providing information and consultancy therefor; testing, inspection or research of cells for gene therapy purposes and providing information and consultancy therefor; testing, inspection or research of cells for research or scientific purposes and providing information and consultancy therefor; research, developments and quality control of cells and consultancy therefor; research, developments and quality control of cells for medical purposes and consultancy therefor; research, developments and quality control of cells for regenerative medical purposes and consultancy therefor; research, developments and quality control of cells for gene therapy purposes and consultancy therefor; research, developments and quality control of cells for research or scientific purposes and consultancy therefor; quality control for others; consultancy services in the field of quality control; consultancy services in the fields of testing, inspection, research or investigation of pharmaceuticals and chemicals; consultancy services about testing, inspection, research or investigation of cells; consultancy services in the fields of testing, inspection, research or investigation of cells for medical purpose; consultancy services in the fields of testing, inspection, research or investigation of cells for regenerative medical purposes; consultancy services in the fields of testing, inspection, research or investigation of cells for gene therapy purposes; consultancy services in the fields of testing, inspection, research or investigation of cells for research or scientific purposes; providing information and consultancy services about testing, inspection or research of pharmaceuticals; providing medical and scientific research information and consultancy services in the fields of testing, inspection or research of pharmaceuticals; custom inspection, analysis, research and development of cells for research or scientific use for others; custom services in the fields of scientific testing, inspection, research or investigation of pharmaceuticals and chemicals; custom inspection, analysis, research, development and design of pharmaceutical agents or pharmaceuticals for others; providing information about inspection, analysis, research, development and design of chemicals, chemical products or proteins; providing medical and scientific research information in the fields of inspection, analysis, research, development and design of chemicals, chemical products or proteins; providing information about inspection, analysis, research, development and design of pharmaceutical agents or pharmaceuticals; providing medical and scientific research information in the fields of inspection, analysis, research, development and design of pharmaceutical agents or pharmaceuticals; research and development in the field of microorganisms and cells; research and development in the field of microorganisms and cells for medical purposes; research and development in the field of microorganisms and cells for regenerative medical purposes; research and development in the field of microorganisms and cells for gene therapy purposes; research and development in the field of microorganisms and cells for research or scientific purposes; conducting clinical trials for others; providing information about clinical trials; providing medical and scientific research information in the field of clinical trials; conducting clinical trials for others in the field of pharmaceuticals; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; research on building construction or city planning; testing or research on prevention of pollution; testing or research on electricity; testing or research on civil engineering; testing, inspection or research on agriculture, livestock breeding or fisheries; providing scientific and research information in the field of bioscience via a website; development and design of manufacturing methods and of testing methods; process monitoring for quality assurance | SECTION 71 - CANCELLED | — |
| 045 | Consultancy services relating to laws and manufacturing regulations; consultancy services relating to laws and medical regulations; legal consultation services; regulatory compliance consulting in the field of pharmaceuticals and [ biologies; ] * biologics * [ agencies for legal procedures relating to lawsuits or other legal issues; ] legal services; providing information in the field of legal standards in the field of manufacturing; advisory services relating to manufacturing regulatory affairs [ ; advice and consultancy services in the field of medical regulatory affairs ] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by NIKON CORPORATION
- Other trademarks owned by NIKON CORPORATION
- Other trademarks owned by NIKON CORPORATION
- Other trademarks owned by NIKON CORPORATION
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 039
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named NIKON
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 31, 2026 | C71T | CANCELLED SECTION 71 | — |
| Apr 24, 2025 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jan 14, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Aug 19, 2021 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Aug 7, 2021 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 9, 2021 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Dec 30, 2020 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Dec 16, 2020 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| Dec 7, 2020 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Dec 7, 2020 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 7, 2020 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 16, 2020 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Sep 25, 2020 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Sep 25, 2020 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Aug 11, 2020 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Aug 10, 2020 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Aug 10, 2020 | PLGL | ASSIGNED TO PARALEGAL | — |
| Jun 12, 2020 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| May 22, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 23, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 23, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 14, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 14, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 29, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 29, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 25, 2019 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 9, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 9, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 9, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 23, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 18, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 18, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 13, 2019 | ALIE | ASSIGNED TO LIE | — |
| Sep 9, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 29, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 9, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 9, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 2, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 28, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 27, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 26, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 26, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 25, 2019 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Feb 21, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |